Radiotherapy and Chemotherapy in Low-Grade Glioma (LGG)

Behzad Saberi
Additional contact information
Behzad Saberi: Medical Research, Iran

Cancer Therapy & Oncology International Journal, 2019, vol. 14, issue 3, 64-65

Abstract: Although optimal timing is unclear, but radiotherapy is an important component of therapy for LGG. Early and delayed radiotherapy can be used for LGG depending on some factors like tumor associated symptoms and presence of risk factors determining the outcome. Poor prognostic factors can be incomplete resection, MIB-1 index elevation, astrocytic histology, more than 40 year of age, absence of 1p/19q-codeletion, large sizes and mutation in isocitrate dehydrogenase.

Keywords: juniper publishers:oncology journals; oncology research journals; oncology journal articles; oncology and cancer case reports; oncology journal of clinical and experimental cancer research; open access; open access journals; Oncology International Journal; juniper publishers reivew (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/ctoij/pdf/CTOIJ.MS.ID.555889.pdf (application/pdf)
https://juniperpublishers.com/ctoij/CTOIJ.MS.ID.555889.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jctoij:v:14:y:2019:i:3:p:64-65

DOI: 10.19080/CTOIJ.2019.14.555889

Access Statistics for this article

Cancer Therapy & Oncology International Journal is currently edited by Sophia Mathis

More articles in Cancer Therapy & Oncology International Journal from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().